About BleuConsult
BleuConsult is a clinical operations calibration platform built for early-stage biotech teams. It combines founder-level clinical operations expertise with structured AI tooling — including the oPoS risk-assessment engine, the 14 Killer Factors framework, VeriAbyss™ consistency review, protocol review, Resource Store, and live clinical-trial intelligence — to help teams pressure-test clinical operations, vendor and CRO oversight, data readiness, documentation discipline, regulatory-facing workflows, and execution risk before small gaps turn into expensive delays.
The platform is designed for new biotech spin-outs, Series A biotech companies, founder-led clinical and health innovation teams, and under-resourced clinical organizations that are moving quickly but do not yet have mature sponsor-level infrastructure in place. Whether a team is preparing for vendor selection, study start-up, investor diligence, AI workflow implementation, or data-readiness planning, BleuConsult provides a focused first look at the operational risk forming underneath the science.
BleuConsult is built and led by Cassandra Harrison, a clinical operations specialist focused on founder-stage biotech teams. The calibration work is supported by the oPoS platform, VeriAbyss consistency review, trial-intelligence tooling, and practical Resource Store materials, but the core value is the combination of clinical operations judgment, founder-stage awareness, structured risk review, and sponsor decision evidence. BleuConsult uses ICH E6(R3)-aligned methodology and keeps AI outputs advisory until qualified human review.
What we do
Combine clinical operations calibration with structured AI tooling — oPoS risk scoring, the 14 Killer Factors framework, VeriAbyss™ consistency review, protocol review, Resource Store implementation tools, and live trial intelligence — to surface operational risk early and turn gaps into decision evidence.
Who it is for
New biotech spin-outs, Series A biotech teams, founder-led health innovation companies, and under-resourced clinical teams moving fast without mature sponsor infrastructure.
Who builds it
BleuConsult, founded and led by clinical operations specialist Cassandra Harrison, focused on founder-stage biotech teams and execution readiness.
Compliance & Transparency
oPoS is an advisory decision-support tool designed to assist clinical trial planning. It does not replace professional regulatory judgment. The methodology is designed to support ICH E6(R3)-aligned assessment, sponsor oversight documentation, and decision evidence. The platform may process business contact information, uploaded protocol materials, and other user-provided content. Do not upload PHI unless appropriate agreements and safeguards are in place. VeriAbyss™ provides AI-assisted consistency review; outputs remain advisory until qualified human review.
© 2026 BleuConsult. All methodologies, frameworks, assessment logic, and library materials are the proprietary intellectual property of BleuConsult. All rights reserved.
All assessments are for informational purposes only.
